ALLISON MILLER: Open Payments
NPI 1912578527 · HAWLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 7 companies in 2025. Trend: 2023 $170 · 2024 $145 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Indivior Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| ABBVIE INC. | 1 | $21 |
| Amgen Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: XIFAXAN, SUBLOCADE, Wegovy, VRAYLAR, OTEZLA, VIVITROL, MOUNJARO.
Industry payments across PA — which companies pay providers there.
